Novo Nordisk’s Wegovy Gets EU Thumbs Up But Launch Will Wait

Based On Positive Phase III Data

 
• By Ayisha Sharma
Non-Diabetic Obese Or Overweight Patients In The STEP Trials Saw 17-18% Weight Loss • Source: Alamy

More from New Products

More from Scrip